Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors

Completed · Phase 1

Conditions studied: Cachexia, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors.

Key facts

Study ID

NCT00014248

Run by

Dartmouth-Hitchcock Medical Center

Starts

2000-10-01

Last updated by the study team

2013-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Norris Cotton Cancer Center — Lebanon, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.